Empowered Funds, LLC
Position in COLL — Collegium Pharmaceutical, Inc
CIK 1592828
NEWTOWN SQUARE, PA
Position in COLL
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$2,045,444
+$147,756 QoQ
Shares Held
56,504
-1.5% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 280 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $76,204,027 across 16 Drug Manufacturers - Specialty & Generic names. COLL ranks #10 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
36,800 | $19,939,342 | |
| 2 | LQDA |
Liquidia Corp
|
210,365 | $16,772,400 | |
| 3 | ZTS |
Zoetis Inc.
|
193,922 | $13,935,230 | |
| 4 | PRGO |
PERRIGO Co plc
|
526,659 | $5,471,987 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
200,073 | $5,075,852 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
162,812 | $3,285,546 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
92,925 | $3,148,299 | |
| 8 | VTRS |
Viatris Inc
|
164,982 | $2,619,910 |
All Filings in COLL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,045,444 | 56,504 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $1,897,688 | 57,384 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,511,695 | 32,650 | Shares | Other | 2026-02-18 | |
| 2024-12-31 | $474,873 | 16,575 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,692,673 | 121,446 | Shares | Other | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||